Related Experiment Video
Updated: Jun 21, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
The natural history of the non-nephrotic membranous nephropathy patient
Michelle A Hladunewich1, Stephan Troyanov, Jennifer Calafati
1University Health Network, University of Toronto, Toronto, Ontario, Canada.
Background And Objectives:
Although early studies suggest that patients with idiopathic membranous nephropathy (MGN) and subnephrotic range proteinuria overall do well, these studies were small and follow-up was short or difficult to discern.
Design, Setting, Participants, & Measurements:
Three hundred ninety-five cases of idiopathic MGN with at least 12 mo of follow-up from the Toronto Glomerulonephritis Registry were reviewed to determine the outcome of the subgroup of patients that presented with subnephrotic range proteinuria. Onset and follow-up data included mean arterial pressure (MAP) and creatinine clearance (CrCl) as determined by the Cockcroft-Gault equation. Outcome variables included the rate of progression (slope of CrCl), 50% reduction in initial CrCl, and end-stage renal disease (ESRD).
Results:
One hundred eight (27% of the total) patients presented with subnephrotic proteinuria and almost 40% (42 of 108) of this subgroup remained subnephrotic. Their long-term slope was -0.93 ml/min/yr. In contrast, those who subsequently developed nephrotic range proteinuria had a progression rate almost four times faster (-3.52 ml/min/yr). The majority who developed nephrotic syndrome did so within the first year of follow-up. The only distinguishing baseline feature between the two groups was a higher level of urine protein in the group that subsequently developed nephrotic syndrome (1.98 [0.3 to 3.4] versus 2.43 [0.5 to 3.4] g/d).
Conclusions:
Patients with MGN and sustained subnephrotic range proteinuria have an excellent prognosis. Conservative management with close monitoring is recommended given the difficulty predicting which patients will develop nephrotic range proteinuria and then progress more rapidly.
Insights
Patients with idiopathic membranous nephropathy (MGN) and subnephrotic proteinuria generally have a good prognosis. Close monitoring is advised, as predicting which patients will develop nephrotic range proteinuria and rapid progression is challenging.
Area of Science:
- Nephrology
- Immunology
- Internal Medicine
Background:
- Idiopathic membranous nephropathy (MGN) is a common cause of nephrotic syndrome in adults.
- Previous studies on MGN with subnephrotic proteinuria had limitations in sample size and follow-up duration.
- The long-term outcomes for patients with MGN presenting with subnephrotic proteinuria require further investigation.
Purpose of the Study:
- To evaluate the long-term outcomes of idiopathic membranous nephropathy (MGN) in patients presenting with subnephrotic range proteinuria.
- To identify predictors of disease progression in this subgroup.
- To inform clinical management strategies for MGN patients with subnephrotic proteinuria.
Main Methods:
- Retrospective review of 395 idiopathic MGN cases from the Toronto Glomerulonephritis Registry with at least 12 months of follow-up.
- Analysis of baseline and follow-up data including mean arterial pressure (MAP) and creatinine clearance (CrCl) using the Cockcroft-Gault equation.
- Outcome variables assessed: rate of CrCl decline, 50% reduction in CrCl, and end-stage renal disease (ESRD).
Main Results:
- 108 patients (27%) presented with subnephrotic proteinuria; 40% of these maintained subnephrotic levels with a slow CrCl decline (-0.93 ml/min/yr).
- Patients who developed nephrotic range proteinuria exhibited a significantly faster progression rate (-3.52 ml/min/yr), with most developing it within the first year.
- Higher baseline urine protein levels were associated with subsequent development of nephrotic syndrome.
Conclusions:
- Idiopathic membranous nephropathy (MGN) patients with sustained subnephrotic proteinuria demonstrate an excellent long-term prognosis.
- Conservative management and close monitoring are recommended due to the difficulty in predicting which patients will progress to nephrotic range proteinuria.
- Early identification of risk factors may aid in tailoring treatment strategies for MGN.
More Related Videos
09:43Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Diabetic Nephropathy
Nephrons
Acute Kidney Injury III: Clinical Manifestations